Delivery Order SPE2DB22D3016-SPE2DB25FBAH9
- Not listed
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, was awarded a delivery order by the Defense Logistics Agency (DLA) on May 12, 2025, for the supply of Eliquis 5 mg tablets (60-count units). This firm fixed-price delivery order carries a ceiling value of $71,179.72 and is scheduled for ultimate completion by May 13, 2025. The award was made through open competition with no set-aside designation and represents a child contract under...
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, was awarded a delivery order by the Defense Logistics Agency on August 27, 2025, for the supply of Eliquis 5 mg tablets (60-count packaging) with a ceiling value of $1,768.36. This firm fixed price, competitively awarded delivery order represents a continuation of AmerisourceBergen's substantial pharmaceutical supply relationship with the federal government, with performance scheduled for...
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, was awarded a delivery order by the Defense Logistics Agency on July 16, 2025, for the supply of Eliquis 5 mg tablets in quantities of 60 units. This is a firm fixed-price contract with a ceiling value of $1,797.10 and an ultimate completion date of July 17, 2025. The award was made through open competition with no set-aside designation. The place of performance is located in...
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, was awarded a delivery order contract by the Defense Logistics Agency (DLA) on September 12, 2025, for the supply of Eliquis 5 mg tablets in a quantity of 60 units. This firm fixed-price delivery order, valued at $9,921.90, represents a competitively awarded, non-set-aside procurement with an ultimate completion date of September 15, 2025. The contract will be performed at the...
- AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, was awarded a delivery order by the Defense Logistics Agency (DLA) on May 30, 2025, for the supply of Eliquis 2.5 mg tablets (60-count packages) with a ceiling value of $1,570.80. This is a firm fixed price delivery order with an ultimate completion date of June 2, 2025, and no set-aside designation was used in the award. The contract represents a competitive procurement action within the pharmaceutical supply chain...
- AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, was awarded a Delivery Order (Contract No. 4569418933) by the Defense Logistics Agency on September 10, 2025, for the supply of Eliquis 5 mg tablets (60-count packages). The firm fixed-price contract has a ceiling value of $20,822.54 and an ultimate completion date of September 11, 2025. This award was made without a set-aside designation, indicating competitive procurement. The contract represents a continuation of...
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, received a delivery order from the Defense Logistics Agency (DLA) on August 13, 2025, for Eliquis 5 mg tablets in a 60-count package. This competitively awarded, firm fixed-price delivery order carries a ceiling value of $10,815.81 and is set to be completed by August 14, 2025. The contract represents a child award under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with...
- AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, was awarded a delivery order by the Defense Logistics Agency (DLA) on September 18, 2025, for the supply of Eliquis 5 mg tablets (60-count packaging) with a ceiling value of $6,803.26. This is a firm fixed-price, non-set-aside delivery order with an ultimate completion date of September 19, 2025. The contract represents a child award under AmerisourceBergen's larger Indefinite Delivery Contract vehicle with DLA Troop...
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, was awarded a delivery order valued at $2,186.16 by the Defense Logistics Agency on July 22, 2025, for the supply of Eliquis 5 mg tablets (60-count packages). The contract is classified as a firm fixed price delivery order with no set-aside designation, indicating the award resulted from open competition. The ultimate completion date is set for July 23, 2025, with performance occurring at...
- AmerisourceBergen Drug Corp was awarded a delivery order on September 9, 2025, by the Defense Logistics Agency to supply 60 tablets of Eliquis 5 mg for $12,352.75, with final delivery required by September 10, 2025. This competitively awarded, firm fixed-price delivery order represents a continuation of the vendor's substantial pharmaceutical supply relationship with the federal government. The order was fulfilled from AmerisourceBergen's location in Conshohocken, Pennsylvania, where the company...
- SPE2DB22D3016Indefinite Delivery Contract
- SPE2DB22D3016-SPE2DB25FBAH9Delivery Order
AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, was awarded a delivery order by the Defense Logistics Agency on June 25, 2025, for 60 tablets of Eliquis 5 mg. This competitively awarded, firm fixed-price contract has a ceiling value of $6,351.66 and an ultimate completion date of June 26, 2025. The award carries no set-aside designation and represents a child contract under AmerisourceBergen's broader Indefinite Delivery Contract with DLA Troop Support Medical, valued at $999,999,999.00 and running through December 2026. This delivery order is consistent with AmerisourceBergen's extensive portfolio of pharmaceutical supply contracts supporting federal medical procurement needs across the Defense Health Agency, U.S. Coast Guard, and other government healthcare systems. The company serves as a critical vendor within the DLA's Medical Supply Chain, fulfilling a comprehensive range of pharmaceutical products including brand-name and generic medications to support military healthcare programs globally. The prime indefinite delivery vehicle enables flexible procurement of specialty medications and medical supplies across multiple therapeutic domains to meet operational healthcare requirements.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $6.4k | 6/25/25 |